Angiopoietin-2 is increased in severe sepsis: Correlation with inflammatory mediators

Critical Care Medicine

Volumn 35, Issue 1, 2007, Pages 199-206

  Orfanos, Stylianos E ^a,b   Kotanidou, Anastasia ^b   Glynos, Constantinos ^b   Athanasiou, Chariclea ^b   Tsigkos, Stelios ^b   Dimopoulou, Ioanna ^a   Sotiropoulou, Christina ^b   Zakynthinos, Spyros ^b   Armaganidis, Apostolos ^a   Papapetropoulos, Andreas ^b,c   Roussos, Charis ^b  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Angiopoietin 2; Endothelium; Interleukin 6; Lung; Sepsis; Tumor necrosis factor

Indexed keywords

ANGIOPOIETIN 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANALYSIS OF VARIANCE; ANIMAL CELL; APACHE; ARTICLE; BLOOD LEVEL; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LUNG ENDOTHELIUM; MALE; MULTIPLE REGRESSION; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SEPTIC SHOCK; STATISTICAL SIGNIFICANCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; ANALYSIS OF VARIANCE; ANGIOPOIETIN-2; APACHE; CASE-CONTROL STUDIES; CRITICAL ILLNESS; ENDOTHELIUM, VASCULAR; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LINEAR MODELS; LUNG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEPSIS; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845940689     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000251640.77679.D7     Document Type: Article

References (38)

1. Yancopoulos GD, Davis S, Gale NW, et al: Vascular-specific growth factors and blood vessel formation. Nature 2000; 407:242-248
2. Jones N, Iljin K, Dumont DJ, et al: Tie receptors: New modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2001; 2:257-267
3. Maisonpierre PC, Suri C, Jones PF, et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277:55-60
4. Kim I, Kim JH, Moon SO, et al: Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3-kinase/Akt signal transduction pathway. Oncogene 2000; 19:4549-4552
5. Witzenbichler B, Maisonpierre PC, Jones P, et al: Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-receptor tyrosine kinase Tie2. J Biol Chem 1998; 273:18514-18521
6. Hayes AJ, Huang WQ, Mallah J, et al: Angiopoietin-1 and its receptor Tie-2 participate in the regulation of capillary-like tubule formation and survival of endothelial cells. Microvasc Res 1999; 58:224-237
7. Papapetropoulos A, Fulton D, Mahboubi K, et al: Angiopoietin-1 inhibits endothelial cell apoptosis via the Act/survivin pathway. J Biol Chem 2000; 275:9102-9105
8. Gale NW, Thurston G, Hackett S, et al: Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning and only the latter role is rescued by angiopoietin-1. Dev Cell 2002; 3:411-423
9. Tsigkos S, Koutsilieris M, Papapetropoulos A: Angiopoietins in angiogenesis and beyond. Expert Opin Investig Drugs 2003; 12:1-9
10. Thurston G, Rudges JS, Ioffe E, et al: Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000; 6:460-463
11. Kim I, Moon SO, Park SK, et al: Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 2001; 89:477-479
12. Witzenbichler B, Westermann D, Knueppel S, et al: Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005; 111:97-105
13. Jones PF: Not just angiogenesis-wider roles for the angiopoietins. J Pathol 2003; 201:515-527
14. Mandriota SJ, Pepper MS: Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 1998; 83:852-859
15. Kim I, Kim JH, Ryu YS, et al: Tumor necrosis factor-α upregulates angiopoietin-2 in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2000; 269:361-365
16. Caine GJ, Blann AD, Stonelake PS, et al: Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: A comparison with VEGF and Flt-1. Eur J Clin Invest 2003; 33:883-890
17. Chong AY, Caine GJ, Freestone B, et al: Plasma angiopoietin-1, angiopoietin-2 and angiopoietin receptor tie-2 levels in congestive heart failure. J Am Coll Cardiol 2004; 43:423-428
18. Lee KW, Lip GY, Blann AD: Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Circulation 2004; 110:2355-2360
19. Lemieux C, Maliba R, Favier J, et al: Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 2005; 105:1523-1530
20. Roviezzo F, Tsigkos S, Kotanidou A, et al: Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 2005; 314:738-44
21. Pober JS, Cotran RS: The role of endothelial cells in inflammation. Transplantation 1990; 50:537-544
22. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101:3765-3777
23. Orfanos SE, Mavrommati I, Korovesi I, et al: Pulmonary endothelium in acute lung injury: From basic science to the critically ill. Intensive Care Med 2004; 30:1702-1714
24. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
25. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13:818-828
26. Vincent JL, de Mondonca A, Cantraine F, et al: Use of SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Crit Care Med 1998; 26:1793-1800
27. Van der Flier M, van Leeuwen HJ, van Kessel KP, et al: Plasma vascular endothelial growth factor in severe sepsis. Shock 2005; 23:35-38
28. Bencosme A, Warner A, Healy D, et al: Prognostic potential of cytokines, nitrates and APACHE II score in sepsis. Ann Clin Lab Sci 1996; 26:426-432
29. Friedland JS, Porter JC, Daryanani S, et al: Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores, and survival in an intensive care unit. Crit Care Med 1996; 24:1775-1779
30. Van Deventer SJH: Interleukin-6 in bacterial infection and sepsis: innocent bystander or essential mediator? In: Yearbook of Intensive Care and Emergency Medicine. Vincent JL (Ed). Berlin, Springer-Verlag, 1999, pp 43-53
31. Xing Z, Gauldie J, Cox G, et al: IL-6 is an anti-inflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101:311-320
32. Riedemann NC, Guo RF, Ward PA: The enigma of sepsis. J Clin Invest 2003; 112:460-467
33. Trzeciak S, Rivers EP: Clinical manifestations of disordered microcirculatory perfusion in severe sepsis. Crit Care 2005; 9(Suppl 4):S20-S28
34. Czermak BJ, Breckwoldt M, Ravage ZB, et al: Mechanisms of enhanced lung injury during sepsis. Am J Pathol 1999; 154:1057-1065
35. Hubbard NE, Lim D, Mukutmoni M, et al: Expression and regulation of murine macrophage angiopoietin-2. Cell Immunol 2005; 234:102-109
36. Huang YQ, Li JJ, Hu L, et al: Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 2002; 99:1646-1650
37. Fiedler U, Reiss Y, Scharpfenecker M, et al: Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 2006; 12:235-239
38. Parikh SM, Mammoto T, Schultz A, et al: Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 2006; 3:e46